Cytosorbents Corporation
CTSOMedical Devices
$4.40−16.03%As of Oct 29vs prior close
- P/E (TTM)
- –
- From 52W high
- −73.72%
- EPS (LTM)
- -$0.23
- Revenue (YE25)
- $37.1M
- Dividend yield
- 0.00%
Nomior Score
17
Steady ProfileSpeculativeBottom 5% of the scored universe
Growth51
Quality38
Value35
Momentum4
Resilience29
Growth
+16.29%revenue a year over 9 fiscal years
YE16 $9.5MYE25 $37.1M
Connections
Revenue to profitQ2 YE26
The operating loss was 27% of revenue, narrower by 10 pts on a year.
Who owns it
1fund